ALKERMES | Capital De Empréstimo



Loan Capital Alterar Data
AbbVie USD 60.34B 1.83B 2024-12
Acadia Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 285.82M 2024-12
Amgen USD 56.55B 305M 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
J&J USD 30.65B 638M 2024-12
Malin Corporation EUR 0 0 2024-06
Merck USD 34.46B 520M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Otsuka Holdings JPY 160.89B 13.1B 2024-12
Pfizer USD 57.4B 597M 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



ALKERMES Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.